Missouri Gov. Matt Blunt (left) shakes hands with patient Rick Allenbrand of Stockton, Mo., after Blunt signed Senate Bill 567, which requires health insurers to cover primary health-care costs for patients involved in approved phase II clinical trials for cancer. Blunt signed the bill July 7 at the Siteman Cancer Center, where Allenbrand was treated for leukemia by John DiPersio, M.D., Ph.D., the Lewis T. and Rosalind B. Apple Professor of Oncology in Medicine, chief of the Division of Oncology and deputy director of the Siteman Cancer Center. DiPersio and colleagues from Siteman have been working with legislators for 12 years to pass this legislation. Allenbrand is now in remission.